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Abstract: In healthy individuals, a DI can reverse (bronchodilation) or prevent (bronchoprotection) induced airway constriction. For 
  individuals with asthma or COPD, these effects may be attenuated or absent. Previous work showed that the size and duration of a DI 
affected the subsequent response of the airways. Also, increased airway tone lead to increased airway size variability. The present study 
examined how a DI affected the temporal variability in individual airway baseline size and after methacholine challenge in dogs using 
High-Resolution Computed Tomography. Dogs were anesthetized and ventilated, and on 4 separate days, HRCT scans were acquired 
before and after a DI at baseline and during a continuous intravenous infusion of methacholine (Mch) at 3 dose rates (17, 67, and 
200 µg/min). The Coefficient of Variation was used as an index of temporal variability in airway size.
We found that at baseline and the lowest dose of Mch, variability decreased immediately and 5 minutes after the DI (P , 0.0001). In 
contrast, with higher doses of Mch, the DI caused a variable response. At a rate of 67 µg/min of Mch, the temporal variability increased 
after 5 minutes, while at a rate of 200 µg/min of Mch, the temporal variability increased immediately after the DI. Increased airway 
temporal variability has been shown to be associated with asthma. Although the mechanisms underlying this temporal variability are 
poorly understood, the beneficial effects of a DI to decrease airway temporal variability was eliminated when airway tone was increased. 
If this effect is absent in asthmatics, this may suggest a possible mechanism for the loss of bronchoprotective and bronchodilatory effects 
after a DI in asthma.
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Introduction
A sigh or deep inspiration (DI) causes transient   distension 
and relaxation of the airways. For healthy individu-
als, a DI can reverse an induced airway   constriction 
(bronchodilation) or prevent a subsequently induced 
constriction (bronchoprotection).1,2 However, for indi-
viduals with asthma or chronic obstructive pulmonary 
disease (COPD), these effects may be attenuated or 
absent.1,3–11 Underlying reasons for these differences in 
lung disease remain to be determined.
A deep inspiratory maneuver is also commonly 
performed to standardize lung volume history prior 
to measuring lung function. One presumption of this 
maneuver is that all the airways are distended with 
the stretch and then return to some stable size based 
on the balance between the level of tone and inward 
recoil of the airways with the outward recoil of the 
parenchyma. What is not known, however, is how 
uniform is this resultant level of tone. That is, how 
much heterogeneity exists in the response of individ-
ual airways after such a DI.
Although it is well accepted that all airways have 
some degree of baseline tone,12 the extent of this tone 
and thus the airway size changes over some dura-
tion of time, but the cause and the interval for these 
changes are generally not known. Airway narrowing 
has been shown to be heterogeneous in the airways of 
asthmatics and normals, being greater in asthmatics.13 
In previous work from our group, we showed that the 
size of individual airways at baseline in dogs, prior to 
the administration of any spasmogen, varied widely 
in the same animals on different days over weeks and 
months.14 More recently, we extended these observa-
tions to show that with Methacholine (Mch)-induced 
increases in airway tone, this airway size temporal 
variability increased even further.15
Although we know that the mean airway response 
to a deep inspiration can vary depending on the size 
and the duration of the deep inspiration,16,17 the   spatial 
heterogeneity among individual airways following a 
DI has not been investigated. Similarly, little is known 
about the temporal reproducibility of airway responses 
to a DI on repeated occasions. Therefore, the current 
study examined how the size of individual canine air-
ways responded to a deep inspiration at   baseline and 
during methacholine (Mch) challenges on 4 different 
experimental days using High Resolution Computed 
Tomography (HRCT) to measure airway size.
Material and Methods
The  study  protocol  was  approved  by  The  Johns 
  Hopkins Animal Care and Use Committee,   Protocol 
#  DO08H03.  All  handling  of  the  animals  from 
  anesthesia  to  recovery  were  done  in  strict  accor-
dance  with  the  guidelines  presented  in  both  the 
Public  Health  Service  Policy  on  Humane  Care 
and Use of Laboratory Animals (Office of Labora-
tory Animal Welfare, National Institutes of Health, 
Bethesda, MD) and the Guide for the Care and Use 
of  Laboratory  Animals  (Institute  of  Laboratory 
Animal  Resources  Commission  on  Life  Sciences, 
National Research Council, Washington, DC). Five 
dogs weighing approximately 20 kg were anesthe-
tized with pharmaceutical grade thiopental sodium 
(15 mg/kg induction dose followed by 10 mg/kg/
hr intravenous maintenance dose).   Following endo-
tracheal intubation with an 8.0 mm ID endotracheal 
tube, the dogs were placed supine and their lungs 
were ventilated with room air using a volume-cycled 
ventilator (Harvard Apparatus,   Millus, MA) at a tidal 
volume of 15 ml/kg and a rate of 18 breaths/minute. 
A stable depth of anesthesia was monitored by lash 
reflex, heart rate, and respiration, and airway pressure 
and end tidal CO2 were measured and used to assess 
the adequacy of ventilation. After induction of anes-
thesia, during imaging the dogs were paralyzed with 
0.5 mg/kg of succinylcholine to ensure no respira-
tory motion. Following the experimental procedures 
all animals were kept under direct observation until 
they were breathing normally. The investigators and/
or a trained technician remained as long as necessary 
to ensure that no animal received less than adequate 
monitoring until they had fully recovered from the 
anesthesia and exhibited normal behavior.
Protocol
Each dog served as its own control. The dogs were 
anesthetized and ventilated as described above. On 
4  separate  days  randomly  varying  between  1  and 
8 weeks apart, baseline HRCT scans were acquired 
(see below), and the dogs then received a continu-
ous intravenous infusion of methacholine at 3 rates 
in increasing order (17, 67, and 200 µg/min; Sigma 
Chemical, St Louis MO), the middle dose, 67 µg/min, 
was  previously  demonstrated  to  decrease  the  size 
of the airways to approximately 60% of baseline.18 
In  addition,  the  tubing  from  the  ventilator  to  the Airway response variability to a deep inspiration
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  endotracheal tube of the animals had an added large 
bore Y-connector. One branch of the Y went to the 
ventilator,  and  the  other  branch  was  connected  to 
a  constant  pressure  source  set  at  25  cmH2O. This 
source consisted of an underwater overflow fed by 
a line from a high flow oxygen supply. At the start 
of scanning, the ventilator was simultaneously shut 
off, a solenoid valve to the ventilator was closed, and 
another   solenoid to the pressure source was opened 
to the dog for a set amount of time (10 seconds). 
Then  solenoids  were  switched  to  suddenly  expose 
the  trachea  to  atmospheric  pressure  and  the  scans 
were acquired. Scanning was performed immediately 
after the DI (approximately 4 seconds) and 5 min 
after  the  DI.  The  dogs  were  ventilated  normally 
between the scan acquisitions. After completing the 
DI protocol during the final dose of Mch, intravenous 
atropine (0.2 mg/kg) was administered, a dose previ-
ously shown to completely block vagal tone in the 
dog.19 To standardize lung volume history, approxi-
mately 10 minutes prior to the first scan series, the 
airway  pressure  was  increased  to  45 cmH2O,  held 
for   5 seconds and then released and the animals were 
ventilated normally. At each dose and after atropine, 
HRCT scans were acquired to measure airway areas 
and lung volumes.
Imaging and analysis of airways
HRCT scans were obtained with a Sensation-16 scan-
ner (Siemens, Iselin, NJ) using a spiral mode to acquire 
approximately 300 CT images during an 8 second 
breath hold (apnea) at 137 kVp, and 165 mA. The 
images were reconstructed as 1 mm slice thickness and 
a 512 × 512 matrix using a 175 mm field of view and 
a high spatial frequency (resolution) algorithm that 
enhanced edge detection, at a window level of −450 
Hounsfield units (HU) and a window width of 1,350 
HU. These settings have been shown to provide accu-
rate measurement of luminal size as small as 0.5 mm 
in diameter.20,21 For repeated airway measurements in 
a given dog within each experimental protocol, adja-
cent anatomic landmarks, such as airway or vascular 
branching points, were defined and used to measure 
the airway size at the same anatomic cross sections.
The  HRCT  images  were  analyzed  using  the 
  airway analysis module of the Volumetric Image and 
  Display Analysis  (VIDA)  image  analysis  software 
  package (Dept. of Radiology, Division of Physiologic 
  Imaging, Univ. of Iowa, Iowa City, IA) as previously 
described and validated.19,22 The HRCT images were 
transferred to a UNIX-based Sun workstation. An ini-
tial isocontour was drawn within each airway lumen, 
and the software program then automatically located 
the perimeter of the airway lumen by sending out rays 
in  a  spoke-wheel  fashion  to  a  predesignated  pixel 
intensity level that defines the luminal edge of the 
airway wall. Intra- and inter-observer accuracy and 
variability of the software program using this HRCT 
technique in phantoms, consisting of rigid tubes to 
measure known areas, has been previously shown by 
us20 and by others22 to be highly resistant to operator 
bias. After segmentation of the parenchyma from the 
chest wall and mediastinum using a semi-automated 
process, lung volume was calculated in four of the 
dogs by summing the volume of individual voxel ele-
ments contained within the region of interest using 
the validated23–25 Pulmonary Workstation 2 software 
(VIDA diagnostics, Iowa City, IA). The software cal-
culated the tissue/vascular volume and the air volume 
separately.
Data Analysis
First,  for  each  airway  on  each  day  we  calculated 
the airway area post-DI as a percent the area pre-DI 
(%DI = the airway area after the DI divided by the 
airway  area  before  the  DI  times  100).  The  %DI 
was calculated at two time points following the DI: 
1) immediately, T0 (technically at 4 sec after return-
ing airway pressure to atmospheric); 2) five min after 
the  DI,  T5.  To  assess  airway  temporal  variability, 
the coefficient of variation (CV) of the four airway 
luminal  measurements  of  each  airway  at  baseline 
and at each dose of methacholine was calculated (the 
standard deviation of the four airway measurements 
divided by the mean of the four airway measurements 
times 100). Data were analyzed by paired t-test and 
by    one-way  ANOVA  where  appropriate  and  with 
correction  for  multiple  comparisons,  and  multiple 
regression analysis where appropriate (JMP release 
7.0.1,  SAS  Institute,  North  Carolina).  Significance 
was considered if the P-value was ,0.05.
Results
A total of 312 airways for 5 dogs were matched and 
measured with the number of airways measured per 
dog ranging from 44 to 73. Airway size ranged from Brown et al
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2.3 to 21 mm in diameter. For all dogs the mean   relative 
airway size pre-DI, defined as the percentage of max-
imum area of the airway after atropine prior to the DI 
maneuver, was 87% ± 5% (mean ± SD), 74% ± 9%, 
65% ± 12%, and 56% ± 10% at baseline and during 
the Mch infusion of 17, 67, 200 µg/min respectively, 
(P  ,  0.0001  for  all  pairwise    comparisons).  Air 
  volumes in the lungs at FRC pre-DI, as a percent-
age air volume at FRC after complete relaxation of 
the   airways with atropine, were 93% ± 6%, 91% ± 
6%, 90% ± 5%, and 91% ± 5% at baseline and during 
the Mch infusion of 17, 67, 200 µg/min respectively, 
(P = 0.33 for all pairwise comparisons).
Immediately after the release of the DI (T0), the 
mean airway size was increased compared to its pre-DI 
size. The airway size as a percent of pre-DI sizes were 
103% ± 4% (mean ± SD), 108% ± 8%, 111% ± 12%, 
and  114%  ±  12%  for  the  baseline  and  during  the 
Mch  infusion  of  17,  67,  200  µg/min    respectively 
(P , 0.0001 compared to pre-DI). Immediately after 
the DI (T0), there were no significant changes in the 
mean air volume in the lungs compared to its pre-DI 
size (P . 0.05). The mean air volume in the lungs as a 
percentage of maximum air volume were 94% ± 6%, 
93% ± 6%, 92% ± 6%, and 92% ± 6% for the baseline 
and during the Mch infusion of 17, 67, 200 µg/min 
respectively.
Five  minutes  after  the  release  of  the  DI  (T5), 
the  mean  airway  size  remained  slightly  increased 
compared to its pre-DI size. The mean airway size 
as  a  percent  of  pre-DI  sizes  were  104%  ±  15% 
(mean  ±  SD),  107%  ±  7%,  104%  ±  6%,  and 
104% ± 7% for the baseline and during the Mch infu-
sion of 17, 67, 200 µg/min respectively P , 0.0001 
compared to pre-DI). Five minutes after the release 
of the DI (T5), there were still no significant changes 
in the mean air volume in the lungs compared to its 
pre-DI size (P . 0.05). The mean air volume in the 
lungs as a percentage of maximum air volume were 
94% ± 6%, 93% ± 6%, 92% ± 6%, and 92% ± 6% for 
the baseline and during the Mch infusion of 17, 67, 
200 µg/min respectively.
To examine the extent of temporal variability after 
a DI over different days, we calculated the CV for 
the change in airway size for each airway in each 
dog across days for each dose of Mch, again calcu-
lated as the standard deviation of the airway divided 
by the mean of the airway measurements times 100. 
At   baseline, the CV pre-DI for the change in airway 
size for each airway ranged from 0% to 27.7% with 
a mean of 10.9% ± 0.4% (Fig. 1A). The DI caused a 
decrease in airway temporal variability with baseline 
tone. At T0 with the CV for the change in airway size 
for each airway ranged from 0.3% to 14.6% with a 
mean of 5.4% ± 0.2% (Fig. 1A). At T5 the CV with 
baseline tone for the change in airway size for each 
airway ranged from 0.2% to 20.9% with a mean of 
5.7% ± 0.2% (Fig. 1A). After complete relaxation 
of  the  airway  with  atropine,  the  CV  decreased  to 
4.6% ± 0.2% with a range from 0.3% to 17%.
During  exogenous  Mch  contraction,  the  CV 
increased at all concentrations compared to baseline 
(P , 0.0001). There was no difference between the 
CV at the 2 highest concentrations of Mch. The effect 
of the DI on airway temporal variability had a differ-
ent result depending on the level of airway tone. At the 
lowest dose of Mch, similar to baseline, the DI caused 
a decrease in airway temporal variability both imme-
diately and 5 minutes later (P , 0.0001,   Fig. 1B). 
However, at the two higher concentrations of Mch, the 
DI caused inconsistent responses in the change in CV. 
At 67 µg/min of Mch, there was a slight decrease in 
the CV immediately after the DI, but then an increase 
in the CV at 5 minutes (P , 0.0001,   Fig. 1C). At 
200 µg/min of Mch, we saw the opposite effect. There 
was a slight increase in the CV immediately after the 
DI, but then a small decrease in the CV at 5 minutes 
(P , 0.0001,   Fig. 1D).   Furthermore, we also noticed 




















Figure 1A. The CV% for all the airways at baseline (pre-DI = control) and 
immediately (T0) and 5 minutes (T5) after a DI. There was a significant 
decrease in mean airway CV% immediately and 5 minutes after the DI 
(P , 0.0001).Airway response variability to a deep inspiration
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Finally, we performed a multiple regression analy-
sis to account for all of the variable at the same time. 
The CV was the dependent variable, and dog, Mch 
dose, and the time period of measurement (control, 
T0,  and T5)  as  independent  variables. We  are  not 
able to look at airways in different lobes with our 
current software. We found all three variables were 
independently and significantly associated with CV 
(P , 0.0001 for all three). We next compared the 
mean values among each of the independent vari-
ables  using  Tukey’s  HSD  to  correct  for  multiple 
comparisons. For the Mch dose, controlling for the 
other independent variables, there was a significant 
difference in CV among the doses, with the baseline 
(Mch 0 µg/min) having the lowest CV. The 17 µg/min 
and the 67 µg/min doses were not significantly dif-
ferent and had the highest CV. The 200 µg/min dose 
had a CV in the middle that was significant different 
from the other doses. For the time of measurement, 
controlling for the other independent variables, there 




















Figure 1B. The CV% for all the airways during Mch infusion of 17 µg/min 
(pre-DI = control) and immediately (T0) and 5 minutes (T5) after a DI. 
There was a significant decrease in mean airway CV% immediately and 




















Figure 1c. The CV% for all the airways during Mch infusion of 67 µg/min 
(pre-DI = control) and immediately (T0) and 5 minutes (T5) after a DI. 
There  was  a  significant  decrease  in  mean  airway  CV%  immediately 





















Figure 1D. The CV% for all the airways during Mch infusion of 200 µg/min 
(pre-DI = control) and immediately (T0) and 5 minutes (T5) after a DI. 
There  was  a  significant  increase  in  mean  airway  CV%  immediately 
(P , 0.0001) and a significant decrease in CV% 5 minutes after the DI 
(P , 0.0001).
Table 1A–D. The CV% for each dog at baseline and for 
each dose of Mch at control (pre DI) and immediately (TO) 
and 5 minutes (T5) after a DI.
Dog control T0 T5
A. cV% Baseline
1 12.8 6.2 4.7
2 11.0 7.0 9.8
3 7.4 4.8 6.1
4 3.9 4.2 3.8
5 19.8 4.8 3.1
B. cV% Mch = 17 μg/min
1 13.7 9.3 16.4
2 24.5 9.1 18.0
3 22.2 7.7 14.5
4 15.5 8.4 7.0
5 23.2 15.5 8.4
c. cV% Mch = 67 μg/min
1 16.7 19.7 26.9
2 11.7 9.8 10.6
3 21.8 17.6 22.3
4 12.6 12.1 14.4
5 9.3 5.2 14.6
D. cV% Mch = 200 μg/min
1 13.0 35.3 9.6
2 17.0 12.0 12.7
3 16.7 15.4 19.4
4 12.1 11.0 10.6
5 8.0 10.5 5.3Brown et al
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the time periods. The highest CV was at the control 
time period, while the lowest CV was at the T0 time 
period. At the T5 time period, the CV was intermedi-
ate and significantly different from the other two time 
periods. For the dogs, we found differences in the 
CV, controlling for the other independent variables, 
among 4 of the 5 dogs. Dogs 1 and 3 had the highest 
CV and they were not significantly different. Then in 
decreasing order of next highest to lowest CV were 
dogs 2, 5, and finally 4 with the lowest CV, control-
ling for the other independent variables.
Discussion
In this study, we measured the size of individual air-
ways on repeated occasions before and after a deep 
inspiration at baseline and during increasing concen-
trations of Mch. As far as we are aware there are no 
comparable data in the literature in humans or animal 
models that has examined this temporal variability in 
individual airway responsiveness to a deep   inspiration. 
Although as will be discussed below, there have been 
studies that have examined the overall airway response 
to a deep inspiration, these did not provide any insights 
in the spatial or temporal variability after a deep inspi-
ration. While the   temporal variability in baseline air-
way size,12 the response to an exogenous challenge,15 
and the single response to a deep inspiration were pre-
viously studied,16,17 the temporal variability in response 
to a deep inspiration has not been investigated.
We previously demonstrated that airways with any 
level of Mch stimulation had greater temporal variabil-
ity than without Mch.15 Our current results also dem-
onstrate that the temporal variability of the airways 
decreased after the deep inspiration both at baseline 
and during low concentrations of Mch stimulation, 
but this beneficial effect of a deep inspiration was lost 
at  higher  concentrations  of  Mch.    Furthermore,  we 
found that the decreased temporal variability at base-
line and during a low concentration of Mch stimula-
tion was sustained for at least 5 minutes after the deep 
inspiration. At higher concentrations of Mch, the tem-
poral variability fluctuated during the 5 minute after 
the deep inspiration.
Consistent  with  our  previous  observations,  we 
saw  significant  differences  in  the  temporal  vari-
ability among dogs and between days. We also saw 
significant  individual  airway  temporal  variability 
within each dog. Since we were infusing the Mch at 
a    steady-state  constant  concentration,  the  temporal 
variability must be related to intrinsic differences at 
the individual airway level.
experimental methods
To minimize any potential variability associated with 
the methods, all dogs were anesthetized, intubated, 
and ventilated in the same manner at the same time 
of day on each of the four occasions. Furthermore, 
to avoid a varying time course associated with an 
acute aerosol challenge, we administered the spasmo-
gen as a continuous intravenous administration that 
should have reached all the airways with the same 
concentration.  In  addition,  we  waited  20  minutes 
after beginning each dose of the continuous infusion, 
about 4 half-lives longer than the response time for 
the airways to Mch, to assure we were at steady-state 
before acquiring the scans. Locating the same airway 
on different days was straightforward, and has been 
documented in several previous studies.16,17,26–30
The intervals between the repeated studies ranged 
from 1 to 8 weeks and were based on HRCT scanner 
availability. While we strived to maintain compara-
ble intervals between the studies, due to scheduling 
constraints associated with the clinical CT scanner, 
it was not always possible. While constant intervals 
between each study session may have some advan-
tages, there were no indications that the random time 
interval between measurements had any consistent 
effect on our results. This is consistent with our pre-
vious work on baseline sizes,14 where the time inter-
val between the baseline studies also varied widely, 
with no correlation between the length of time and 
the  extent  of  baseline  tone. What  we  still  do  not 
know is the limits of this time frame of temporal 
variability outside of the 1–8 weeks used here. That 
is, how much of this temporal variability might occur 
over shorter intervals of hours or days remains to be 
determined.
To standardize the measurement of airway area, all 
measurements were made by the same person (KF). 
We also only measured airways with a baseline diam-
eter greater than 2 mm in diameter, which has been 
shown to be a size above which there is sufficient 
signal to noise and limited measurement variability 
even after contraction.13 In addition, all the measure-
ments were made at FRC, which was not significantly 
changed either immediately or 5 minutes after the DI.Airway response variability to a deep inspiration
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In previous work,16 we studied the mean effect of 
a DI on the subsequent response of the airways. That 
work showed that a short duration or small size DI 
caused an immediate distension of the airways but led 
to subsequent narrowing of the airways relative to the 
pre-DI size. In contrast, a long duration or large DI 
caused a larger immediate distension of the airways 
and a subsequent maintained dilation of the airways 
up to 5 minutes after the DI. In the current work, we 
chose both a small size and a short duration DI, with 
the expectation we would observe a subsequent con-
traction of the airways 5 minutes after the DI. This 
subsequent contraction at the 5 min point, however, 
was not found in the present study. We believe that 
methodological differences in the two studies may 
account for this difference. In the previous work, we 
acquired the CT scans immediately after the release 
of the DI, every 30 seconds for the next 2 minutes, 
and then every minute for the next 3 minutes. In the 
current study, we only acquired the CT scans imme-
diately after the DI and after 5 minutes. To acquire 
the CT scans, it is necessary to stop the ventilation 
for the duration of the scanning. The previous study 
was performed on an older model scanner that had 
only  4  detectors  and  thus  required  a  significantly 
longer apneic period, about 15 seconds versus about 
7 seconds for the current study. The fact that we also 
stopped the ventilation more times (8 times or ≈ 120 s) 
in the previous studies compared to the current study 
(2 times or ≈ 14 s) may have accounted for the subse-
quent bronchoconstriction we saw previously, since, 
it is well documented that a lack of tidal stretching of 
the airways can lead to spontaneous constriction.31,32 
This effect of tidal volume stretching (or lack thereof) 
also may be relevant to the mechanisms of the DI 
induced  bronchoconstriction  and  bronchodilation 
after a DI in individuals with asthma.33
Another  difference  compared  to  our  previous 
findings is that in the current study, the distension 
of the airways immediately after the DI was smaller 
than what was previously observed.16,17 This is also 
likely due to methodological differences. Our pre-
vious studies examined either changes in duration17 
or changes in size16 of the DI, but not both. At the 
shorter durations, we used a larger size DI, and for the 
experiments with the smaller DIs, we used a longer 
duration. In the current study, we used both a short 
duration and a small size, and this combination could 
have contributed to the small residual airway dilation 
at 5 min after the DI.
Results from the present work show that when there 
was a substantially increased airway tone induced by 
the highest concentrations of Mch, there was a loss of 
the DI’s ability to decrease the airway temporal vari-
ability. However, we did not see a dose response rela-
tionship between the increase in airways tone and the 
temporal variability after the DI. This was surprising, 
since the mean level of airway smooth muscle con-
striction continued to increase with increasing doses 
of Mch, so we would have expected the temporal vari-
ability to also change accordingly from the lowest to 
the highest dose of Mch. This observation suggests that 
there might be a threshold beyond which additional 
muscle tone no longer leads to a beneficial effect of 
a DI. It is interesting that this lack of a dose response 
relationship with regard to airway tone is consistent 
with the response to a DI in subjects with asthma of 
varying severity compared to healthy individuals.2,8 
Scichilone et al demonstrated no difference in either 
the bronchodilatory or bronchoprotective effects of a 
DI in the individuals with mild asthma compared to 
those with moderate to severe disease.8 The lack of a 
dose-response effect is also consistent with our recent 
work in dogs examining airway temporal variability 
with increased airway tone.34 In a related study, Que, 
et al35 found increased temporal variability in human 
respiratory  resistance  after  Mch  challenge.  They 
assumed this resulted from intrinsic rapid fluctuation 
in each of the hundreds of conducting airways lying 
in series and parallel that was increased with Mch. 
How this temporal variability would be altered by a 
DI was not studied by Que, et al, but if their untested 
assumption about the smooth muscle tone is true, the 
expectation would be that if the airways are dilated 
(as with a DI), there would be less temporal variabil-
ity. Why there is an all or none response with regard 
to Mch dose, however, is not clear and is something 
that warrants further study.
While we did not measure transpulmonary pressure, 
we did measure lung volumes from the HRCT scans at 
baseline and immediately and 5 minutes after the DI. 
Colebatch et al36 showed that when boluses of smooth 
muscle agonists were administered in the   pulmonary 
artery of cats and dogs, there were transient decreases 
in lung volume and dynamic compliance, and increases 
in transpulmonary pressure. However, we did not see Brown et al
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any decrease in lung   volume at any of the steady state 
doses of Mch that we administered, either immediately 
or 5 minutes after the DI maneuvers. The difference in 
these studies may reflect the effect that a bolus injec-
tion into the pulmonary artery causes extremely high 
acute concentrations that are quickly diluted, so even 
our highest steady state doses may not be comparable 
with the boluses given by Colebatch et al.36
In asthma, the loss of the bronchoprotective effect of 
a DI is one the earliest pathologic changes observed.8 
Even individuals with mild asthma show a loss of bron-
choprotection.6 If we can extrapolate from our data, we 
would predict that while a large change in tone is not 
required to increase the temporal variability after a DI, in 
order to lose the bronchoprotective effects of a DI, even 
modest changes in tone may be sufficient. However, this 
extrapolation cannot be carried too far, since, the remod-
eling and changes in airway smooth muscle mass that 
have been shown to exist in asthmatic individuals37–39 
could not possibly explain the differences we observed 
in the same airways of healthy dogs after a DI.
At  the  present  time,  we  can  only  offer  several 
speculations  for  the  difference  in  temporal  vari-
ability in the airway response to DI observed with 
Mch challenges. Variations in local vagal tone and 
its response to a large stretch could result in release 
of local mediators that would contribute to this tem-
poral variability, but unfortunately there is no infor-
mation  on  either  the  spatial  distribution  of  vagal 
tone to the airways or its temporal variation even in 
the absence of DIs. Similarly, ignorance exists with 
regard to temporal and spatial variations in the inter-
stitial milieu bathing the airways, so the effect of any 
local mediator or nitric oxide release is unknown. 
One source of temporal variability relevant to the 
large stresses associated with a DI is perhaps related 
to the slowly adapting (SAR) and rapidly adapting 
pulmonary stretch receptors in the lung. Many SARs 
are known to be active at FRC,40 and since increased 
SAR activity with the lung inflation phase of a DI 
would surely cause   bronchodilation, any decrease in 
SAR activity during the relaxation phase will lead 
to a variable degree of bronchoconstriction. Perhaps 
the most likely explanation is that the airway smooth 
muscle  itself  is  responsible  for  both  the  widely 
  varying response to exogenous stimulation and DI, 
as suggested by work of Que, et al.35 In a study by 
Frey et al41 using a   fractal model, it was shown that 
increased  temporal  variability  in  peak  expiratory 
flows was associated with the most severe asthmatics 
and with an increased risk of unstable airway func-
tion. King et al using HRCT scans also demonstrated 
increase airway narrowing heterogeneity in asthma 
compared to healthy   individuals.13 The potential rel-
evance of the temporal variability in responsiveness 
to Mch and to DIs could be resolved with studies 
that follow individual airway responses over time in 
asthmatic or normal subjects.
In conclusion, results from this study document 
a differential temporal variability in airway size fol-
lowing a DI depending on the level of airway tone. 
Increased airway tone led to increased airway temporal 
variability. At high levels of airway tone, the beneficial 
effects of a DI were abolished. While the mechanisms 
underlying this temporal variability are poorly under-
stood, if we consider that 1) increased heterogeneity 
may exacerbate clinical disease, and 2) that the bron-
choprotective and bronchodilatory effect of a DI on 
the airways is lost in individuals with asthma, then we 
speculate that we would likely find a smaller decrease 
in airway temporal variability after a DI in asthmatic 
subjects compared to healthy individuals.
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